Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
30 Leser
Artikel bewerten:
(0)

Platform Development, Earnings, Contest Launch, Company Recognition, and Upcoming Events - Research Reports on Cognizant, TripAdvisor, Salesforce.com, FireEye and Synaptics

NEW YORK, August 6, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Cognizant Technology Solutions Corporation (NASDAQ: CTSH), TripAdvisor Inc. (NASDAQ: TRIP), Salesforce.com Inc. (NYSE: CRM), FireEye, Inc. (NASDAQ: FEYE) and Synaptics Inc. (NASDAQ: SYNA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5493-100free.

--
Cognizant Technology Solutions Corporation Research Reports
On July 24, 2014, Cognizant Technology Solutions Corporation (Cognizant) announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a unique, subscription-based platform which will transform the way clinical sites collaborate with pharma companies on clinical trials. As per Cognizant, the new platform will enhance organizational productivity by providing investigators and site staff with a central, single access point to clinical trial information, enhancing accuracy, and reducing study start-up time. It will also help companies to improve quality, regulatory compliance, and capacity, while reducing investigator efforts related to training, document exchange, and support. "We are pleased to partner TransCelerate to build this platform, which will help maximize the potential of technology-based collaboration and provide better medicines to patients, greater efficiency to clinical sites, and superior business outcomes to sponsors," said Bhaskar Sambasivan, Vice President, Cognizant's Life Sciences. The full research reports on Cognizant are available to download free of charge at:

http://www.analystsreview.com/Aug-06-2014/CTSH/report.pdf

--
TripAdvisor Inc. Research Reports
On July 31, 2014, TripAdvisor Inc. (TripAdvisor) announced the launch of the TripAdvisor TV Ad Contest, its first-ever user-generated ad contest. The Company has urged everyone from video amateurs to filmmakers to submit a short video in the spirit of TripAdvisor's "Don't Just Visit" commercials between August 1, 2014 and August 31, 2014. The contest winner will earn a grand prize of $25,000 and a chance to see their ad air on television. TripAdvisor will also award five runner-up prizes of $1,000 with winning videos shared on TripAdvisor social media channels. Barbara Messing, Chief Marketing Officer for TripAdvisor, said, "Travelers love sharing their experiences on TripAdvisor, so we're excited to get their take on our 'Don't Just Visit' ads by asking them to share their travel stories in a creative new way, with one winning story to air on TV." The full research reports on TripAdvisor are available to download free of charge at:

http://www.analystsreview.com/Aug-06-2014/TRIP/report.pdf

--
Salesforce.com Inc. Research Reports
On July 25, 2014, Salesforce.com Inc. (Salesforce.com) reported that the Company has been positioned by Gartner, Inc. in the "Leaders" quadrant for its Salesforce1 Sales Cloud solution, for the eighth consecutive year. As per Salesforce.com, Salesforce1 Sales Cloud accelerates the sales of leading companies like LinkedIn, SoundCloud, Trulia and Zimmer. "We believe the Salesforce Sales Cloud continues to set the bar for the Sales Force Automation industry-this is our eighth consecutive year positioned in the Leaders quadrant for Gartner," said Linda Crawford, EVP and GM of Sales Cloud, Salesforce.com. The full research reports on Salesforce.com are available to download free of charge at:

http://www.analystsreview.com/Aug-06-2014/CRM/report.pdf

--
FireEye, Inc. Research Reports
On August 1, 2014, the shares in FireEye, Inc. (FireEye) fell 7.38% from its previous day's close and closed the trading session at $32.88. The stock opened at $35.19, touched an intra-day high of $35.63 and a low of $32.26. A total of 6.73 million shares changed hands, significantly higher than the previous day's trading volume of 3.11 million shares. The stock has a 52-week high of $97.35, which it touched on March 5, 2014. The full research reports on FireEye are available to download free of charge at:

http://www.analystsreview.com/Aug-06-2014/FEYE/report.pdf

--
Synaptics Inc. Research Reports
On August 4, 2014, Synaptics Inc. (Synaptics) announced that members of the executive management team will present to the investment community at the Pacific Crest Global Technology Leadership Forum on, August 12, 2014 at 9:00 a.m. Mountain Time, in Vail, Colorado. In a separate press release on July 31, 2014, Synaptics announced its Q4 FY 2014 earnings (period ended June 30, 2014). Net revenue grew 36.8% YoY to $314.9 million, while net income was $34.5 million or $0.89 per diluted share. Adjusted net income grew 16.1% YoY to $56.8 million or $1.46 per diluted share in Q4 FY 2014. Kathy Bayless, CFO, said, "With continued strength in our core focus areas and fingerprint ID solutions now successfully incorporated into our platform, we feel confident that we can achieve another year of very strong annual revenue growth in the mid-20% range, excluding revenue from our impending acquisition of Renesas SP Drivers." The full research reports on Synaptics are available to download freeof charge at:

http://www.analystsreview.com/Aug-06-2014/SYNA/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Analysts Review

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.